NCT02055183View on ClinicalTrials.gov

BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum Antitoxin

CompletedOBSERVATIONAL
Enrollment

162

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Botulism
Interventions
DRUG

BAT

Noninterventional, retrospective, observational phase 4 patient Registry

Sponsors
All Listed Sponsors
collaborator

Biomedical Advanced Research and Development Authority

FED

collaborator

Centers for Disease Control and Prevention

FED

lead

Emergent BioSolutions

INDUSTRY